Sisram Medical to Announce 2025 Annual Results on Monday, March 23, 2026

Core Viewpoint - Sisram Medical Ltd will announce its audited consolidated results for the year ended December 31, 2025, on March 23, 2026, followed by an earnings conference call on March 24, 2026, to discuss the financial results [1]. Group 1: Company Overview - Sisram Medical Ltd (1696.HK) is a global leader in medical aesthetic solutions with over 25 years of expertise in Energy-Based Devices (EBD) [1]. - The company offers a synergistic ecosystem that includes EBD technologies, injectables, diagnostics, and complementary solutions, serving customers in over 110 countries and regions [1]. - Sisram Medical is majority-owned by Fosun Pharma and has been listed on the Main Board of the Hong Kong Stock Exchange since September 2017 [1]. Group 2: Earnings Announcement Details - The earnings conference call will feature prepared remarks from key management, including the Chairman, CEO, Co-CEO and CFO, Secretary of the Board, and Investor Relations Director [1]. - Participants can join the conference calls by completing online registration prior to the scheduled call start time, with sessions available in both Chinese and English [1]. - A replay of the conference calls will be accessible on the company's website shortly after the events [1].